These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7237460)

  • 1. Ifosfamide treatment of pancreatic cancer.
    Gad-El-Mawla N; Ziegler JL
    Cancer Treat Rep; 1981; 65(3-4):357-8. PubMed ID: 7237460
    [No Abstract]   [Full Text] [Related]  

  • 2. Ifosfamide plus 5-fluorouracil for treatment of adenocarcinoma of the pancreas.
    Loehrer PJ; Williams SD; Nichols CR
    Cancer Treat Rep; 1987 Nov; 71(11):1115-6. PubMed ID: 3119208
    [No Abstract]   [Full Text] [Related]  

  • 3. Ifosfamide: an active drug in the treatment of adenocarcinoma of the pancreas.
    Loehrer PJ; Williams SD; Einhorn LH; Ansari R
    J Clin Oncol; 1985 Mar; 3(3):367-72. PubMed ID: 3973647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trofosfamide in patients with pancreatic cancer.
    Schmidt-Sandte W; Dageförde J; Klapdor R; Wagner T; Wiedemann GJ
    Anticancer Res; 1999; 19(4A):2485-7. PubMed ID: 10470179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytostatic treatment of hypernephroid renal carcinoma (author's transl)].
    König HJ; Hartwich G
    Dtsch Med Wochenschr; 1980 Dec; 105(52):1810-4. PubMed ID: 7449648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450.
    Löhr M; Müller P; Karle P; Stange J; Mitzner S; Jesnowski R; Nizze H; Nebe B; Liebe S; Salmons B; Günzburg WH
    Gene Ther; 1998 Aug; 5(8):1070-8. PubMed ID: 10326030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
    Loehrer PJ; Williams SD; Einhorn LH
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):72-5. PubMed ID: 6836331
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer.
    Eckel F; Lersch C; Lippl F; Assmann G; Schulte-Frohlinde E
    J Exp Clin Cancer Res; 2000 Sep; 19(3):295-300. PubMed ID: 11144522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of malignant ovarian tumors; therapeutic results of ifosfamide.
    Yakushiji M; Tsunawaki A; Nishida T; Nishimura H; Natsuaki Y; Inoue T; Kato T
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1071-6. PubMed ID: 7304132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ifosfamide in the treatment of solid tumors and their metastases].
    Wicart L
    Nouv Presse Med; 1976 Apr; 5(15):996-8. PubMed ID: 778786
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of Iphosphamide in phracological treatment of neoplasms].
    Madej G; Zelechowska JA
    Pol Tyg Lek; 1975 Jun; 30(22):955-7. PubMed ID: 1135071
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial with ifosfamide in pancreatic cancer.
    Wils JA; Kok T; Wagener DJ; Francois E; Selleslags J; Duez N
    Eur J Cancer; 1993; 29A(2):290. PubMed ID: 8422302
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of pain caused by metastases of reactivated prostatic cancer with ifosfamide].
    Kawai T; Takeda T; Kihara K; Sakuramoto T; Satomi Y
    Gan No Rinsho; 1983 Aug; 29(10):1085-91. PubMed ID: 6632195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ifosfamide chemotherapy ineffective for advanced pancreatic carcinoma].
    Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Kanda Y; Yamato A; Terashi K; Suda Y
    Gan To Kagaku Ryoho; 1997 Mar; 24(5):569-72. PubMed ID: 9087289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and safety of high-dose ifosfamide.
    Holoye PY; Anderson T; Duelge J; Hansen RM; Ritch PS
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):78-86. PubMed ID: 6298946
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium.
    Sutton GP; Blessing JA; DeMars LR; Moore D; Burke TW; Grendys EC
    Gynecol Oncol; 1996 Oct; 63(1):25-7. PubMed ID: 8898163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study.
    Nose H; Okada S; Okusaka T; Furuse J; Yoshino M; Ogoshi K; Kato T; Miyaji M; Hoshino M; Ariyama J; Suyama M; Karasawa E; Yoshimori M
    Hepatogastroenterology; 1999; 46(30):3244-8. PubMed ID: 10626195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with fractionate massive-dose Ifosfamid therapy of generalized malignant tumors].
    Hoefer-Janker H; Scheef W; Günther U; Hüls W
    Med Welt; 1975 May; 26(20):972-9. PubMed ID: 1094226
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy in resectable pancreatic cancer.
    Irmscher S; Senninger N; Schleicher C
    Ann Surg Oncol; 2008 Jul; 15(7):2059-60; author reply 2061. PubMed ID: 18266042
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of cell therapy as a means of targeting chemotherapy to inoperable pancreatic cancer.
    Günzburg WH; Salmons B
    Acta Biochim Pol; 2005; 52(3):601-7. PubMed ID: 16175235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.